TriSalus Life Sciences, Inc.
TLSI
NASDAQ·Healthcare·Medical - Devices·Mkt cap $307.9M
$5.00
▲ +0.40%
P/E
-3.85
Mkt Cap
$307.9M
52-Wk Range
$2.20–$7.95
52-Week Range
$2.20 - $7.95
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 0.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary pressure-enabled drug delivery technology for targeted tumor treatment
- Dual-platform approach combining medical devices with immunotherapeutics
- Direct infusion systems that maximize local drug concentration while minimizing systemic exposure
- Focused pipeline addressing underserved liver and pancreatic cancer indications
Bear Case
1 risk
- Low volatility (beta 0.4).
Growth
Moderate growth ahead
Clinical advancement and potential FDA approval of SD-101 for multiple cancer indications
Value
Deep value opportunity - significant discount to Medical Devices peers
Momentum
Hot
+55.8% over 3m
Quality
Excellent
Solid business
Dividend
None
No dividend
Smart-money signal
Who's buying TLSI right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 12, 2026
AUG 6, 2026
Reported EPS of -$0.16 vs -$0.16 consensus (-3.2% surprise). Revenue of $11.4M vs $10.3M expected (+11.1%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-3.2%
Revenue trend · last 8Q
—
+44%
+42%
+52%
+57%
+60%
-3%
+2%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$7.3M
$8.3M
$9.2M
$11.2M
$11.6M
$13.2M
$8.9M
$11.4M
Margins · last 8Q
Gross
86.8%
Operating
-86.0%
Profit
-80.5%
Wall Street consensus
1 analyst · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Lake Street · $8.00 · May 13, 2026
vs Industry
How TLSI stacks vs Medical - Devices
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related